The registration for this conference has ended. RegistrationCenter

Webinar Date

Wednesday, January 10, 2018
 Add to Calendar  Add to Calendar
1:00 PM Eastern 12:00 PM Central
11:00 AM Mountain 10:00 AM Pacific

Doctors, nurses, and other health care professionals learn about the newest myeloma treatments and management practices by attending national medical meetings. With its new webinar, Making Sense of Myeloma Treatment Advances: Updates from the 2017 American Society of Hematology Annual Meeting, the MMRF brings this information to the audience that matters most: myeloma patients, their families, and their caregivers.

The information in this webinar will empower participants to advocate for achieving the best possible outcome for their disease by providing timely information that helps them understand the important progress being made in myeloma today.

Two convenient ways to participate:

  • By phone
  • Online

I would like to register for this webinar:

  Updates from the 2017 American Society of Hematology Annual Meeting
Wednesday, January 10, 2018, 1:00 PM ET

If you are unable to register online or do not receive your confirmation email after registering (don't forget to check your spam email folder), please contact our Registration Desk at 866-872-5840 (international callers please dial 617-502-2061). You can also contact us by email Send Email

There is no fee for attending this webinar. To register, please complete the required information and click Submit.

*Indicates required information.

Please note, a registration confirmation will be sent to this email address.

By providing your mobile phone number, you agree to receive a text reminder for this activity. Standard text messaging rates may apply.

Please provide the names and email addresses of additional participants who will be joining you on the webinar.

First name Last name Email


As part of our registration process, we ask you to complete the pre-webinar evaluation below:

1. *How much do you agree with the following statements?

I am knowledgeable about the myeloma treatment options that are available.

I know about the latest drugs under clinical investigation for myeloma.

I understand the role that clinical trials play in helping get new drugs approved for myeloma.

I know what myeloma resources are available to me.

I know who to contact if I have any questions about my treatment.

I am prepared to discuss my treatment plan with my health care team.

2. Please list a question about multiple myeloma (to be addressed by myeloma experts during the webinars)

Powered by BeaconLive